Want to see IN:JUBLINGREA full AI Analyst Report?
JUBLINGREA Stock Chart & Stats
₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)
Day’s Range― - ―
52-Week Range₹535.30 - ₹794.95
Previous CloseN/A
Volume517.05K
Average Volume (3M)13.09K
Market Cap
₹117.80B
Enterprise Value₹93.20K
Total Cash (Recent Filing)₹1.90B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)38.0
Beta1.02
Next Earnings
Oct 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.67%
Share Statistics
EPS (TTM)19.54
Shares Outstanding159,281,140
10 Day Avg. Volume10,350
30 Day Avg. Volume13,091
Financial Highlights & Ratios
PEG Ratio2.89
Price to Book (P/B)2.75
Price to Sales (P/S)1.96
P/FCF Ratio52.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.05
Revenue Forecast (FY)₹52.06B
Bulls Say, Bears Say
Bulls Say
Diversified Product Portfolio And End MarketsJubilant Ingrevia serves multiple end markets (pharma, agrochemicals, food/nutrition) and sells both specialty and intermediate products. This multi-segment B2B mix reduces single-market cyclicality, enables cross-selling, and supports durable revenue streams as demand shifts across sectors.
Manageable Leverage And Growing Equity BaseA moderate debt-to-equity (~0.25) and steady equity growth provide balance-sheet resilience, supporting capital allocation and investment capacity. Manageable leverage gives the company flexibility to fund capex or absorb cyclical downturns without immediate refinancing stress.
Consistent Positive Operating Cash FlowSustained positive operating cash flow indicates the core manufacturing operations generate real cash, enabling working-capital funding and reinvestment. Even with volatile FCF, predictable OCF supports operational continuity and funding of incremental growth or maintenance capex.
Bears Say
Weak Cash Conversion And Volatile Free Cash FlowEarnings are not consistently translating to cash, with low cash conversion ratios and swings in free cash flow. Over the medium term this constrains organic investment capacity, increases dependence on external financing for growth, and raises vulnerability to working-capital stress.
Declining Margins And Reduced Capital EfficiencyLower margins and a material drop in ROE indicate deteriorating profitability and capital efficiency versus prior cycles. If sustained, weaker margins reduce internal cash generation and limit ability to fund margin-accretive investments, making performance more sensitive to raw-material or pricing shocks.
Modest And Inconsistent Revenue GrowthRevenue recovery has been uneven, with only modest growth recently following declines and flat periods. This inconsistent top-line trend complicates long-term planning, constrains scalable margin improvement, and signals exposure to end-market cycles or product-mix shifts that limit reliable growth.
Jubilant Ingrevia Ltd. News
JUBLINGREA FAQ
What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹794.95 in the past 12 months.
What is Jubilant Ingrevia Ltd.’s market cap?
Jubilant Ingrevia Ltd.’s market cap is ₹117.80B.
When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
Jubilant Ingrevia Ltd.’s upcoming earnings report date is Oct 21, 2026 which is in 71 days.
How were Jubilant Ingrevia Ltd.’s earnings last quarter?
Jubilant Ingrevia Ltd. released its earnings results on Jul 22, 2026. The company reported ₹6.7 earnings per share for the quarter, the consensus estimate of ₹6.7 by ₹0.
Is Jubilant Ingrevia Ltd. overvalued?
According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued.
Does Jubilant Ingrevia Ltd. pay dividends?
Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.67%. See more information on Jubilant Ingrevia Ltd. dividends here
What is Jubilant Ingrevia Ltd.’s EPS estimate?
Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jubilant Ingrevia Ltd. have?
Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
Jubilant Ingrevia Ltd. reported an EPS of ₹6.7 in its last earnings report, expectations of ₹6.7. Following the earnings report the stock price went down -2.813%.
Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
Currently, no hedge funds are holding shares in IN:JUBLINGREA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited, established in 2019 and based in Noida, India, is a global supplier of life science products and comprehensive solutions. The company's operations are divided into three core divisions: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment delivers a variety of specialized ingredients, fine chemicals, and crop protection agents, in addition to offering custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division focuses on ingredients for both human and animal nutrition and well-being. Meanwhile, the Life Science Chemicals segment provides crucial life science components and a range of specialized ethanol products. Jubilant Ingrevia's extensive portfolio encompasses numerous chemical offerings, including a broad spectrum of pyridine derivatives (such as picolines, cyanopyridines, and various substituted pyridines), essential vitamins like B3 and riboflavin phosphate sodium, and nutritional compounds like premixes and antioxidants. They also produce industrial chemicals like acetic anhydride, ethyl acetate, and various alcohols (absolute alcohol, ethanol), alongside biocompost and gas mixtures. Furthermore, the company supplies a wide array of animal health and nutrition additives, including mineral premixes, stress regulators, amino acids, herbal growth promoters, toxin binders, and enzymes. Beyond its product range, Jubilant Ingrevia offers specialized services in chemical synthesis, covering everything from initial route design and process optimization to scaling up production and commercial manufacturing of intermediates. The company serves a diverse client base across the pharmaceutical, nutrition, agrochemical, consumer goods, and industrial sectors. Originally incorporated as Jubilant LSI Limited, the company adopted its current name, Jubilant Ingrevia Limited, in October 2020.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Piramal Pharma Limited
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―







